Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-453
TNBC
Luminal
IKK16
IKK
NFKB
7516.093
uM
2.96630
3.9210
-0.9563 -0.9566 3.8322 0.4483
0.9950
1.3148
MDA-MB-453
TNBC
Luminal
IKK16
IKK
NFKB
7517.093
uM
2.74660
3.69310
-0.9214 -0.9311 3.5511 0.4269
0.9966
1.4869
MDA-MB-453
TNBC
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7515.092
uM
16.4390
27.87260
-0.9604 -1.0000 2.0808 0.5674
0.9718
1.2024
MDA-MB-453
TNBC
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7517.091
uM
9.01190
21.99220
-0.8943 -0.9738 1.2117 0.5607
0.9732
1.5552
MDA-MB-453
TNBC
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7516.092
uM
18.17450
22.59320
-0.9966 -0.9844 5.0000 0.5268
0.9905
1.1035
MDA-MB-453
TNBC
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7518.091
uM
8.46120
19.06220
-0.9155 -0.9875 1.3423 0.5638
0.9937
1.6174
MDA-MB-453
TNBC
Luminal
Ispinesib
KSP
Kinesin
7517.067
uM
0.03439
0.03835
-0.9658 -0.3627 5.0000 0.6845
0.8934
1.3778
MDA-MB-453
TNBC
Luminal
Ispinesib
KSP
Kinesin
7518.067
uM
0.01798
0.02415
-0.9983 -0.6977 2.9622 0.9323
0.9711
0.7666
MDA-MB-453
TNBC
Luminal
Ixabepilone
TUBB
TUBB
7515.095
uM
inf
inf
-0.9794 -0.9794 0.0000 0.7184
0.4831
0.9628
MDA-MB-453
TNBC
Luminal
Ixabepilone
TUBB
TUBB
7517.095
uM
0.00457
0.00486
-0.9304 -0.0633 1.9640 0.6882
0.6096
1.5365
MDA-MB-453
TNBC
Luminal
Ixabepilone
TUBB
TUBB
7516.095
uM
0.00981
0.01007
-0.9552 -0.0706 4.9999 0.6551
0.6098
1.3423
MDA-MB-453
TNBC
Luminal
Ixabepilone
TUBB
TUBB
7518.095
uM
0.00193
0.00223
-0.8913 -0.1868 2.2259 0.8555
0.7508
1.4438
MDA-MB-453
TNBC
Luminal
JNK-IN-5A
JNK
JNK
12414.168
uM
1.270
1.37520
-0.4961 -0.2441 4.9964 0.5078
0.8906
1.2069
MDA-MB-453
TNBC
Luminal
L-779450
BRAF
MAPK
12414.166
uM
inf
1000.00000
0.6341 -0.0841 0.2717 0.1078
0.7545
1.3106
MDA-MB-453
TNBC
Luminal
Lapatinib
EGFR/HER2
ErbB
7516.098
uM
25.84260
677.19180
0.5439 -1.0000 0.3364 0.1388
0.7417
1.2625
MDA-MB-453
TNBC
Luminal
Lapatinib
EGFR/HER2
ErbB
7515.098
uM
17.48960
1.53090
0.4989 0.4585 1.0219 0.1186
0.8334
1.1465
MDA-MB-453
TNBC
Luminal
Lapatinib
EGFR/HER2
ErbB
7518.098
uM
6.77860
86.09230
0.3255 -1.0000 0.4322 0.1598
0.9481
1.6108
MDA-MB-453
TNBC
Luminal
Lapatinib
EGFR/HER2
ErbB
7517.098
uM
2.410
2.00280
0.1796 0.0889 1.0580 0.1698
0.9748
1.2851
MDA-MB-453
TNBC
Luminal
LBH589
HDAC
HDAC
12414.167
uM
0.04797
0.05925
-0.9352 -0.9371 5.0000 0.9336
0.9987
1.2130
MDA-MB-453
TNBC
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12414.167
uM
0.64209
1.94630
-0.9565 -1.0000 0.9907 0.4364
0.9913
1.2130
MDA-MB-453
TNBC
Luminal
Mebendazole
12964.174
uM
0.21977
0.29241
-0.4032 -0.2943 1.6205 0.5795
0.9637
0.7885
MDA-MB-453
TNBC
Luminal
Mebendazole
13562.174
uM
0.10597
0.12962
-0.3553 -0.2507 2.0171 0.6156
0.9838
0.7219
MDA-MB-453
TNBC
Luminal
Methotrexate
DHFR
Metabolism
7517.084
uM
inf
0.03602
0.6571 0.7142 0.6438 0.1970
0.8099
1.4076
MDA-MB-453
TNBC
Luminal
Methotrexate
DHFR
Metabolism
7518.084
uM
inf
0.10744
0.7409 0.7877 5.0000 0.1325
0.8790
1.3244
MDA-MB-453
TNBC
Luminal
Methylglyoxal
13647.184
uM
inf
inf
-0.8749 -0.8749 0.0000 0.3852
0.4269
1.2942